TYMS and colorectal carcinoma: 5-Fluorouracil (5-FU) is a cornerstone in CRC treatment, primarily inhibiting thymidylate synthase (TS) to disrupt DNA synthesis by depleting intracellular deoxynucleotide pools (Vodenkova et al., 2020).